KRAS linked to gene shifts in brain AVM cells

By AI, Created 5:03 PM UTC, May 18, 2026, /AGP/ – A study in the Chinese Neurosurgical Journal finds that overexpressing KRAS in human microvascular endothelial cells triggers thousands of gene-expression changes tied to adhesion, transport and mitochondrial function. The findings add a molecular clue to how brain arteriovenous malformations may develop and point to possible future therapeutic targets.

Why it matters: - Brain arteriovenous malformation, or bAVM, is a rare brain vascular disorder that can rupture and cause intracranial hemorrhage. - bAVM carries a high risk of severe neurological complications, especially in children and young adults. - The study adds evidence that KRAS may be a key driver of the molecular changes behind bAVM development and progression. - The results could help narrow future work on treatment targets tied to vascular stability and endothelial function.

What happened: - Researchers from Peking Union Medical College Hospital and Beijing Tiantan Hospital studied molecular changes linked to bAVM pathogenesis in human microvascular endothelial cells, or HMEC-1. - The team overexpressed KRAS in HMEC-1 cells using a lentiviral construct and then ran RNA sequencing and pathway analysis. - The paper was published online in Chinese Neurosurgical Journal on March 1, 2026, in Volume 12, Article 7.

The details: - RNA sequencing found 4,737 differentially expressed genes in KRAS-overexpressing cells. - The dataset included 2,619 upregulated genes and 2,118 downregulated genes. - Many upregulated genes mapped to cell adhesion structures, including focal adhesions, adherens junctions and cell-substrate junctions. - Enriched molecular functions included cadherin binding and cell adhesion molecule binding. - Enriched biological processes included Golgi vesicle transport, nuclear transport and endomembrane system organization. - Most downregulated genes were associated with ribosomes and mitochondrial protein complexes. - The study links altered proteoglycan expression and weaker adherens junction integrity to possible changes in vascular remodeling and barrier stability in bAVM. - The gene pattern also suggests dysfunctional mitochondrial activity and reduced biosynthetic capacity, which could affect endothelial stability. - The paper frames KRAS-driven metabolic dysfunction as a possible contributor to bAVM pathogenesis. - The original article is titled “RNA-seq analysis reveals altered gene expression profiles in HMEC-1 cells overexpressing KRAS gene associated with brain arteriovenous malformation.” - The DOI is 10.1186/s41016-026-00427-9. - The study was an experimental cell study. - The authors reported no competing interests. - The work was supported by China’s National Key Research and Development Program, the Natural Science Foundation of China, the Beijing Municipal Administration of Hospitals Incubating Program and the Natural Science Foundation of Beijing.

Between the lines: - The study is mechanistic, not clinical, so it points to biology rather than proving a treatment strategy. - The lack of visible shape changes in the cells after 72 hours suggests KRAS can alter endothelial biology before obvious morphological damage appears. - The strongest signal centers on adhesion, transport and mitochondrial pathways, which fits a disease model built around unstable vessel walls and disrupted cell-cell interactions. - The authors say future studies should validate the protein-level effects and account for cellular heterogeneity, extracellular matrix complexity and hemodynamic forces in real bAVMs.

What’s next: - Future work will need protein validation to confirm whether the RNA changes translate into functional effects. - Researchers will also need models that better capture the physical and structural environment of bAVMs. - The study opens a path for testing whether KRAS-linked pathways can serve as therapeutic targets in bAVM.